Cipla New Ventures
Profile and portfolio
Cipla New Ventures is the corporate venture arm of Cipla, a pharmaceutical and biotech company. Sectors it names: biotech and life sciences, healthcare and digital health.
Every figure links to its source
Snapshot
Where it invests
Key facts
History
- Cipla sells its entire stake in Chase Pharma, reported four-fold return (2016-11-23)S3
Portfolio
Public sources name 4 portfolio companies.S1
Every company on the Cipla New Ventures list
4 companies, as named in the sources cited.S1 Read the firm's list.
- BioMab
- Chase Pharma
- MabPharma
- Stempeutics
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Cipla New Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.